CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel diseaseDavid J. Friedman, Simon C. Robson, Eva Csizmadia et al.|Proceedings of the National Academy of Sciences|2009Cited by 284
Upregulation of CD39/NTPDases and P2 receptors in human pancreatic diseaseBeat Künzli, Simon C. Robson, Pascal O. Berberat et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|2006Cited by 160
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancerBeat Künzli, Simon C. Robson, Christoph A. Maurer et al.|Purinergic Signalling|2011Cited by 124